Cell type | Probe sets in cell-specific signaturea | Overlap with erythropoiesis signatureb | Overlap observedc | Overlap expectedd |
---|---|---|---|---|
CD4+ T lymphocytes | 211 | 0 | 0 | 0.9% |
CD8+ T lymphocytes | 252 | 0 | 0 | 1.1% |
CD14+ monocytes | 447 | 0 | 0 | 2.0% |
CD19+ B lymphocytes | 272 | 1 | 2.0% | 1.2% |
CD56+ NK cells | 265 | 0 | 0 | 1.2% |
CD33+ myeloid lineage | 448 | 0 | 0 | 2.0% |
CD34+ stem cells | 227 | 4 | 8.2% | 1.0% |
CD105+ mesenchymal stem cells/endothelial precursors | 360 | 18 | 36.7% | 1.6% |
CD71+ erythroid precursors | 563 | 39 | 79.6% | 2.5% |
BDCA4+ dendritic cells | 372 | 0 | 0 | 1.7% |